search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
INDUSTRY FOCUS Chemical & Pharmaceutical y


Quality control in an inhaler testing line


D


elivering quality medicaments is a must for pharmaceutical manufacturers, as it ensures that the treatment is safe and


therapeutically effective. When producing metered dose inhaler (MDI) canisters, typically used for respiratory drug delivery for people suffering from Asthma, it is essential that all products released into the market can generate a suitable aerosol of a drug formulation. To do so, it is necessary to fill the canisters with an optimum level of liquefied gas under pressure, then test for gas leaks and dispose of any faulty canisters. While detecting gas propellant leaks in MDI


canisters is of utmost importance, conventional, non-automated methods suffer from a number of limitations. Automation can address these issues and help pharmaceutical manufacturers to improve their profitability. In particular automated testing helps move away from manual, off-line leak inspections – which slow down production and reduce overall volumes. Embracing in-line or at-line testing means operators do not need to physically collect samples and can achieve a rapid uplift in productivity. In addition, by installing automated systems


it is also possible to increase accuracy, by testing each individual canister. Conventional leak detection is conducted as an end-of-line test on one or a few samples from each batch. This means that if a single canister is defective, the entire batch may be scrapped, resulting in high wastage, cost and poor efficiency. On the other hand, if the sample examined passes the quality control test, this does not exclude the possibility of off spec items remaining in the batch, which may enter the market.


Automation brings a breath of fresh air in inhaler manufacturing These benefits were particularly appealing to a forward-looking manufacturer of pressurised MDI (pMDI) canisters, that wanted to drive performance in its quality control strategies. To implement a reliable,


36 June 2020 | Automation


A manufacturer specialising in asthma inhalers has transformed its in-line testing operations thanks to an automated quality control solution developed by Mitsubishi Electric and Optimal Industrial Automation


advanced system, the pharmaceutical company contacted Optimal, an expert in process control and system integration. Nigel Penny, project manager at Optimal


Industrial Automation, comments: “We knew that the application would require a high level of accuracy and repeatability in position control to effectively move and monitor the pMDI canisters. Mitsubishi Electric offers very reliable and accomplished small robots which are easy to synchronise and control, using powerful controllers and intuitive software. We also appreciate the technical support and assistance offered, which helps to deliver the type of advanced tailor-made solutions we specialise in.” The innovative, automated leak detection


system developed by Mitsubishi Electric and Optimal consists of a carousel conveyor running at constant speed and composed by 86 cavity holders, known as ‘pucks’. These hold the individual canisters and transport them through a tunnel, designed to help concentrate any gas leakage by sealing the top and bottom of the pucks. A sensitive laser gas analyser is used to test the air surrounding the canisters. If an item is found to be defective and leaking even a tiny amount of propellant gas it is discarded. Operators can monitor the process in real-time via Mitsubishi Electric’s MAPS SCADA platform, which shares information with the gas analysers.


The importance of fully synchronised robots


The system uses two Mitsubishi Electric FR- Series four-axis SCARA robots, which position the canisters correctly into the moving puck as well as place all items that pass through the leak testing onto an outfeed conveyor. The ‘pick-and-place’ robots are


controlled by a powerful iQ Platform PLC to ensure exact synchronisation. This allows the robot to handle moving canisters without the need to stop the conveyor, avoiding any interruption on the line. Martin Gadsby, director at Optimal


Industrial Automation, explains: “Synchronisation on this line is critical because the canisters are unstable and may topple unless the motion of the robots and conveyors matches perfectly.” Steve Kirby, key account manager at Mitsubishi Electric, adds: “The iQ series PLC is ideal to meet the levels of speed and accuracy required by the system. The controller executes command processes in a matter of nanoseconds. It also offers a high-speed data logger module, where the sampling function is synchronised with the sequence scan.” This latter aspect further helped to create a


comprehensive and intelligent set up. In effect, Mitsubishi Electric and Optimal allowed the PLC to interact with the gas analyser, process and log the results of each individual pMDI test as well as offering exportable reports of canister analytical data for each batch.


Bringing quality control to the next level


The resulting leak detection system, now fully operational, can process 180 pMDI canisters per minute and reject individual defective items, rather than entire batches. As a result, pharmaceutical manufacturers could benefit from substantial reductions in waste generation, whilst optimising its use of resources and the overall production plant.


CONTACT:


Mitsubishi Electric Europe Web: gb3a.mitsubishielectric.com


automationmagazine.co.uk


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44